Lymphoma
📧 Sign up to get email alerts when something new happens for Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-11-12Clinical Trial Update: Safety and Tolerability Study for T-1301 Capsules to Treat Advanced Solid Tumors [Phase 1]
A Phase 1 safety and tolerability study of T-1301 capsules for advanced solid tumors and lymphoma is currently recruiting.
-
CLINICAL_TRIALS research · 2024-11-08Clinical Trial Update: The SOAR Study: a Study of Geriatric Assessment and Exercise for Older Adults and Their Support Person [NA]
The SOAR study is a clinical trial evaluating geriatric assessment and exercise for older adults and their support persons across multiple c…
-
CLINICAL_TRIALS trial_result · 2024-11-07Clinical Trial Update: The In4M Study: Integrating 4 Methods to Assess Physical Function in Cancer Patients
The In4M study, a trial evaluating four methods to assess physical function in cancer patients, has completed, including participants with b…
-
CLINICAL_TRIALS trial_result · 2024-11-06Clinical Trial Update: A Study to Learn About the Study Medicine (Called Maplirpacept (PF-07901801)) in Japanese With Hematologic Malignancies [Phase 1]
Pfizer's Maplirpacept (PF-07901801) Phase 1 trial in hematologic malignancies (lymphoma and multiple myeloma) has completed enrollment/statu…
-
CLINICAL_TRIALS trial_result · 2024-11-01Clinical Trial Update: Safety and Pharmacokinetic Study of RRx-001 in Cancer Subjects [Phase 1]
Phase 1 safety and pharmacokinetic data for RRx-001 in cancer patients; the trial (solid tumors and lymphomas) has completed and results wer…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: A Dose Escalation and Expansion Study of ASP4132 to Subjects With Advanced Refractory Tumors and Lymphoma [Phase 1]
Phase 1 dose-escalation and expansion study of ASP4132 in patients with lymphoma and solid tumors has completed.
-
CLINICAL_TRIALS research · 2024-10-18Clinical Trial Update: Eltrombopag for Peripheral Blood Stem Cell Harvest [Phase 2]
A Phase 2 clinical trial in Taiwan is evaluating eltrombopag to improve peripheral blood stem cell harvest in patients with lymphoma undergo…
-
CLINICAL_TRIALS research · 2024-10-16Clinical Trial Update: Exercise as an Immune Adjuvant for Allogeneic Cell Therapies [EARLY_Phase 1]
An early-phase clinical trial is exploring whether exercise can boost immune response as an adjuvant to allogeneic cell therapies, with recr…
-
CLINICAL_TRIALS research · 2024-10-10Clinical Trial Update: Clinical Trial of HG146 Administered to Subjects with Advanced Solid Tumors or Lymphoma [Phase 1]
This entry reports a Phase 1 study of HG146 in subjects with advanced solid tumors or lymphoma. The sponsor is HitGen Inc., and the current …
-
CLINICAL_TRIALS trial_result · 2024-10-02Clinical Trial Update: Study of the Bromodomain (BRD) and Extra-Terminal Domain (BET) Inhibitors BMS-986158 and BMS-986378 in Pediatric Cancer [Phase 1]
Phase 1 study of BRD/BET inhibitors BMS-986158 and BMS-986378 in pediatric cancers has completed enrollment.
-
CLINICAL_TRIALS trial_result · 2024-09-25Clinical Trial Update: Impact of Chemotherapeutic Treatments in Patients Aged 75 Years and Over Treated for Lymphoid Hematological Malignancy [NA]
Completed clinical trial assessing the impact of chemotherapeutic treatments in patients aged 75 and older with lymphoid hematological malig…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Safety and Efficacy of Anti-CD20/CD30 CAR-T Cells in Subjects with Relapsed/Refractory Lymphoma [EARLY_Phase 1]
This document describes an early-phase (Phase 1) clinical trial evaluating anti-CD20/CD30 CAR-T cells in patients with relapsed or refractor…
-
CLINICAL_TRIALS trial_result · 2024-09-05Clinical Trial Update: BeEAM Versus CEM in Lymphoma Patients as a Conditioning Regimen Before Autologous Hematopoietic Cell Transplantation [NA]
Completed clinical trial comparing BeEAM versus CEM conditioning regimens in lymphoma patients undergoing autologous hematopoietic cell tran…
-
CLINICAL_TRIALS research · 2024-09-05Clinical Trial Update: Flow Cytometry for the Study of T-Cell Populations in Hemophagocytic Lymphohistiocytosis Associated With Lymphomas
A clinical trial investigating flow cytometry to study T-cell populations in lymphoma-associated hemophagocytic lymphohistiocytosis, current…
-
CLINICAL_TRIALS trial_result · 2024-08-27Clinical Trial Update: A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors on PD1/PDL1 Inhibitor Therapy [Phase 2]
This Phase 2 trial assesses the safety and immunogenicity of the Moderna COVID-19 vaccine (mRNA-1273) in patients with solid tumors and hema…
-
CLINICAL_TRIALS research · 2024-08-27Clinical Trial Update: A Real-World Study on Extranodal Lymphoma
A real-world study on extranodal lymphoma is registered at Ruijin Hospital and is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2024-08-23Clinical Trial Update: Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Baricitinib at Children and Young Adults With Hemoblastosis [Phase 2, Phase 3]
Phase 2/Phase 3 trial evaluating a combination of post-transplant cyclophosphamide, abatacept, vedolizumab, and baricitinib to prevent graft…
-
CLINICAL_TRIALS research · 2024-08-15Clinical Trial Update: iPSC Neurons From Adult Survivors of Childhood Cancer Who Have Persistent Vincristine-Induced Neuropathy
Clinical trial update examining iPSC-derived neurons from adults who survived childhood cancer and have persistent vincristine-induced neuro…
-
CLINICAL_TRIALS research · 2024-08-14Clinical Trial Update: Glucose Intolerance and Diabetes Related to Treatment With Steroids and PEG- Asparaginase in Children and Adolescents With ALL and Lymphoma
A clinical trial update evaluating glucose intolerance and diabetes related to steroid and PEG-asparaginase treatment in children and adoles…
-
CLINICAL_TRIALS trial_result · 2024-08-12Clinical Trial Update: A Study of Chinese Adults With Lymphoma
This entry notes the completion of a Takeda-sponsored clinical study evaluating a treatment for lymphoma in Chinese adults.
-
CLINICAL_TRIALS trial_result · 2024-08-06Clinical Trial Update: ACY-1215 for Relapsed/Refractory Lymphoid Malignancies [Phase 1, Phase 2]
Clinical trial update for ACY-1215 (ricolinostat) in relapsed/refractory lymphoid malignancies reports Phase 1/2 results; the study has been…
-
EMA approval · 2024-07-31EMA Authorised: Mozobil (Plerixafor) — Sanofi B.V.
The EMA authorised Mozobil (plerixafor) from Sanofi B.V. for multiple myeloma and lymphoma indications, including use in hematopoietic stem …
-
CLINICAL_TRIALS trial_result · 2024-07-31Clinical Trial Update: Dose Escalation and Efficacy Study of mRNA-2416 for Intratumoral Injection Alone and in Combination With Durvalumab for Participants With Advanced Malignancies [Phase 1, Phase 2]
This clinical trial update reports dose-escalation and preliminary efficacy findings for intratumoral mRNA-2416 as a standalone therapy and …
-
CLINICAL_TRIALS research · 2024-07-31Clinical Trial Update: Early Integration of Palliative and Supportive Care in Cellular Therapy [NA]
This clinical trial is evaluating early integration of palliative and supportive care in cellular therapy for hematologic cancers and is cur…
-
CLINICAL_TRIALS research · 2024-07-29Clinical Trial Update: TSN222 in Subjects With Advanced Solid Tumors or Lymphomas [Phase 1, Phase 2]
Phase 1/2 trials are evaluating TSN222 in adults with unresectable locally advanced or metastatic solid tumors or lymphoma, and the study is…